Barclays
NXTM

Barclays’s NxStage Medical Inc. NXTM Stock Holding History

Barclays’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,700
Closed -$213K – 7267
2017
Q3 		$213K Buy
+7,700
New +$205K ﹤0.01% 4374

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Barclays's NXTM Position: Q1 2019 in Review

Barclays sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 47,281 shares — an estimated $1.35M sold.

Barclays first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $11M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Barclays reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Barclays sold 47,281 NxStage Medical Inc. shares in Q1 2019, an estimated $1.35M.
  • Barclays first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
  • Barclays's NxStage Medical Inc. position peaked at $11M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.